American Herbal Products Association (AHPA) > News > Press Room

Press Room

Our Mission

The American Herbal Products Association (AHPA) is the national trade association and voice of the herbal products industry. Founded in 1982, AHPA's mission is to promote the responsible and sustainable commerce of herbal products to ensure that consumers have informed access to a wide variety of safe herbal goods. AHPA’s Vision is for high quality herbal products to be readily accessible to and broadly used by consumers.

Our Expertise

AHPA has particular expertise on the history, science, and regulation of botanicals while its work also has significant influence on non-herbal dietary supplements. Similarly, AHPA expends its resources on issues in the U.S. marketplace and in the international arena, wherever member interests are served.

Our Members

AHPA is comprised of more than 350 domestic and international companies conducting business as growers, processors, manufacturers, and marketers of herbs and herbal products. AHPA members’ herbal products are in tea, beverage, dietary supplement, sports nutrition, personal care, pet and other product categories. AHPA membership also includes individuals, companies and organizations who serve the industry, including consultants, attorneys, media, researchers, educators, and medical professionals.

Learn more about AHPA >>

AHPA Press Releases and Updates for the Media

June 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The June 2020 AHPA Report includes snapshots of global COVID-19 responses that impact the international supplement industry, FDA & FTC COVID-19 warning letters target social media and intravenous therapies, RFP for slippery elm  sustainable wild harvest study, updated Hemp-CBD Status Report, and more.

Free primer on Convention on International Trade in Endangered Species (CITES)

Free primer on Convention on International Trade in Endangered Species (CITES)

AHPA continues work with the CITES Plants Committee and the U.S. Fish Wildlife Service to promote sustainable harvests

Updated in May 2020, this free primer helps members and the herbal products industry understand the processes and practices that must be followed to comply with CITES requirements when importing and exporting species listed on CITES appendices

Request for proposals: Slippery elm sustainable wild harvest study

Request for proposals: Slippery elm sustainable wild harvest study

Deadline extended to July 10, 2020

The AHPA Foundation for Education and Research on Botanicals (AHPA ERB Foundation) is issuing a request for proposals to award grant funding to eligible applicants in order to enhance and promote knowledge and understanding of sustainable harvest of slippery elm (Ulmus rubra).  The grant supports research effects of varying rates of wild slippery elm bark harvest on tree population health and recovery across multiple harvest sites in order to inform sustainable harvest and management decisions for the species. The anticipated amount of funding available for a sustainable wild slippery elm bark harvest research project is up to $10,000 annually for up to 5 years.

Webinar: Marketing Claims for Hemp-Derived Products

Presented May 20, 2020 -- Duration: 2.5 hours

This webinar provides guidance and practical tips on how to successfully market your hemp-derived products consistent with the requirements of the FDA and FTC. An FTC representative provides FTC’s perspective, summarizes recent enforcement actions, and discusses the level of substantiation respondents in those actions possessed or did not possess. Industry attorneys address legal standards, today’s ever-evolving regulatory environment, and the lawsuit risks and liabilities marketers of hemp products face.

May 2020 AHPA Report & 2019 Annual Report

AHPA Members, Log in to access the AHPA Report

The May 2020 AHPA Report includes the 2019 AHPA Annual Report, the 2020 AHPA Awards, AOAC Official Method of Analysis for cannabinoids in hemp, free cGMP webinars, AHPA advocacy in Oregon, supply chain issues, and more.

AHPA Hemp-CBD Status Report

Updated in April 2020 to cover recent FDA and USDA actions • Log-in to download

To help the herbal products industry understand the evolving regulatory landscape for hemp and hemp-derived cannabidiol (CBD) products, AHPA has updated its free Hemp-CBD Status Report to include recent actions taken by the Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA).

AOAC Scientists Approve Official Method of Analysis for Cannabinoids in Hemp

April 27, 2020: AHPA Chief Science Officer Dr. Holly Johnson chairs CASP working group involved creating requirements for testing standard

The new validation and approval will allow laboratories to evaluate hemp for tetrahydrocannabinol (THC) on a dry-weight basis, as described by the U.S. Department of Agriculture’s Interim Final Rule governing the production of hemp under the 2018 Agriculture Improvement Act, known as the Farm Bill.

Free webinar: Supplement cGMP Basics for Hemp-CBD Companies

Presented Dec. 10, 2019 -- Duration: 2 hours

This webinar provides an overview of dietary supplement current good manufacturing (cGMP) requirements for hemp-CBD products. Legal and industry experts provide strategies and resources to comply and document compliance with  federal manufacturing requirements designed to ensure supplement product quality and safety.

Free webinar: Preparing for FDA cGMP Facility Inspections

Presented December 17, 2019

This webinar is designed to help businesses in the dietary supplement industry understand the elements of current Good Manufacturing Practice (cGMP) regulations (21 CFR 111) that have been the primary focus of FDA inspections. This knowledge will assist businesses in better allocating and directing their compliance resources.

Oregon adopts temporary rule prohibiting unsubstantiated claims that goods prevent, treat, diagnose, or mitigate COVID-19 related conditions

April 17, 2020: AHPA has been working with other trade organizations to seek withdrawal of a much-broader proposed rule that the OR DOJ published for comment late last year and in amended form in March 2020.

The Oregon Department of Justice (OR DOJ) has temporarily adopted a rule declaring it “unfair and deceptive” (and thus unlawful) to represent that any product “will prevent, treat, diagnose, mitigate, or cure coronavirus, COVID-19 or a related condition, without first having competent and reliable scientific evidence upon which to base a reasonable belief in the truth of the representation.” The temporary rule is effective for six months, until October 14, 2020.
RSS
12345678910 Last

2022 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.